Decreased Risk of Periprosthetic Joint Infection with Concurrent Hardware Removal During Conversion Total Hip

Sean B Sequeira1, Mark D Hasenauer, Robert McKinstry

  • 1From the Department of Orthopaedic Surgery, MedStar Union Memorial Hospital, Baltimore, MD.

Insights

Hardware removal before hip replacement surgery increases the risk of periprosthetic joint infection (PJI). However, the timing of hardware removal does not impact revision surgery, fracture, or loosening rates.

Area of Science:

  • Orthopaedic Surgery
  • Biomedical Engineering
  • Clinical Outcomes Research

Background:

  • Hardware removal prior to conversion total hip arthroplasty (cTHA) presents surgical challenges.
  • Optimal timing for hardware removal to minimize complications post-cTHA remains unclear.

Purpose of the Study:

  • To evaluate the impact of hardware removal timing on complications following cTHA.
  • To compare the risks of revision surgery, periprosthetic joint infection (PJI), periprosthetic fracture, and aseptic loosening between concurrent and staged hardware removal.

Main Methods:

  • A national insurance database was used to identify 7,756 patients undergoing hardware removal and cTHA.
  • Patients were divided into concurrent (same-day) and staged (within 1 year prior) hardware removal groups.
  • Matched cohorts of 2,752 patients each were analyzed for 90-day and 1-year complication rates.

Main Results:

  • The staged cohort showed significantly higher rates of PJI at 90 days (3.05% vs 1.85%) and 1 year (4.14% vs 2.94%) compared to the concurrent cohort.
  • No significant differences were found in the rates of fracture, revision surgery, or aseptic loosening between the groups.
  • Diabetes, tobacco use, and obesity were identified as risk factors for PJI.

Conclusions:

  • Staged hardware removal prior to cTHA is associated with an increased risk of PJI.
  • The timing of hardware removal does not appear to affect the risk of revision surgery, fracture, or loosening.
  • Surgeons should consider these findings when managing patients with periarticular implants requiring cTHA.
Abstract